Outcome of Hepatitis E Virus Infection in Patients With Inflammatory Arthritides Treated With Immunosuppressants
Hélène Bauer(Hôpital d'Hautepierre), Jean Sibilia(Immunologie, Immunopathologie et Chimie Thérapeutique), Pascal Claudepierre(Hôpitaux Universitaires Henri-Mondor), Florence Abravanel, Daniel Wendling(Centre Hospitalier Universitaire de Besançon), Guillaume Lefèvre(Université de Lille), Alain Cantagrel, Jean‐Marie Péron, Anna Moltó(Inserm), Yves‐Marie Pers(University of Ljubljana), Christophe Hudry, Christelle Sordet, Anne‐Marie Roque‐Afonso(Hôpital Paul-Brousse), Béatrice Pallot-Pradès, Martin Soubrier(Centre Hospitalier Universitaire de Clermont-Ferrand), C. Roux(Hôpital Pasteur), Emmanuel Chatelus(Laboratoire National de Référence), Jacques Izopet(Hôpital Purpan), Laurent Marguerie, Claire Veissier, Antoine Martin(Hospital General Universitario Gregorio Marañón), Jacques‐Eric Gottenberg(Centre National de la Recherche Scientifique), Laurent Messer, Cécile Luxembourger, Sylvie Fabre, Sophie Fournier
Cited by 60
Related Papers
A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis
|New England Journal of Medicine|2018|605
A multicenter, randomized, double‐blind, placebo‐controlled trial of adjuvant methotrexate treatment for giant cell arteritis
|Arthritis & Rheumatism|2002|574
<i>MUC5B</i> Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease
|New England Journal of Medicine|2018|501
Adipose Mesenchymal Stromal Cell-Based Therapy for Severe Osteoarthritis of the Knee: A Phase I Dose-Escalation Trial
|Stem Cells Translational Medicine|2016|493
Incidence and Prevalence of Systemic Sclerosis: A Systematic Literature Review
|Seminars in Arthritis and Rheumatism|2007|456